Horizon Therapeutics (HZNP) – Major News
-
Amgen (AMGN) Completes Acquisition of Horizon Therapeutics
-
Horizon Therapeutics (HZNP) and Amgen (AMGN) Resolve FTC Lawsuit, Clear Path to Close Acquisition
-
Amgen (AMGN) Settles With FTC On $27.8 Billion Horizon Deal - Bloomberg
-
Horizon Therapeutics (HZNP) Tops Q2 EPS by 19c
-
FTC Will Sue To Block Amgen's (AMGN) Deal To Buy Horizon Therapeutics (HZNP) - Bloomberg
-
Horizon Therapeutics (HZNP) Misses Q1 EPS by 37c
-
Horizon Therapeutics (HZNP) Tops Q4 EPS by 12c
-
Amgen (AMGN) acquires Horizon (HZNP) for $26 billion as Sanofi (SNY) drops bid
-
Amgen (AMGN) in advanced talks to acquire Horizon Therapeutics (HZNP) - WSJ
-
Horizon Therapeutics (HZNP) Confirms Talks on Takeover With Three Large Pharma Cos.
-
Horizon Therapeutics (HZNP) Tops Q3 EPS by 19c; Raises Outlook
-
Horizon Therapeutics (HZNP) Misses Q2 EPS by 26c
-
Horizon Therapeutics (HZNP) Tops Q1 EPS by 20c; Maintains Outlook
-
Horizon Therapeutics (HZNP) Tops Q4 EPS by 6c
-
Horizon Therapeutics (HZNP) Tops Q3 EPS by 22c
-
Horizon Therapeutics (HZNP) Tops Q2 EPS by 74c; Raises Outlook
-
Horizon Therapeutics (HZNP) Misses Q1 EPS by 13c, Offers FY Guidance
-
Horizon Therapeutics (HZNP) Tops Q4 EPS by 22c, Revenues Beat; Offers FY21 Revenue Guidance Above Consensus
-
Horizon Therapeutics (HZNP) to Acquire Viela Bio (VIE) for $53 Per Share in $3.05 Billion Deal
-
Horizon Therapeutics (HZNP) Tops Q3 EPS by 77c, Raises FY Revenue Guidance
-
Horizon Therapeutics (HZNP) Tops Q2 EPS by 4c on Revenue Blowout, Raises Outlook
-
Horizon Therapeutics (HZNP) Tops Q1 EPS by 18c, Raises FY Rev. Guidance
-
Horizon Therapeutics (HZNP) Tops Q4 EPS by 13c, Offers Guidance
-
Horizon Pharma (HZNP) Confirms FDA Advisory Committee Votes Unanimously to Support Use of Teprotumumab for Treatment of Thyroid Eye Disease
-
Horizon Pharma (HZNP) Tops Q3 EPS by 15c, Offers Guidance
-
Horizon Pharma (HZNP) Tops Q2 EPS by 11c, Raises FY Guidance
-
Horizon Pharma (HZNP) Tops Q1 EPS by 18c, Revenues Beat; Raises FY19 Revenue Guidance Above Consensus
-
Horizon Pharma (HZNP) Tops Q4 EPS by 13c, Offers FY Guidance
-
Horizon Pharma (HZNP) Tops Q3 EPS by 15c
-
Horizon Pharma (HZNP) Tops Q2 EPS by 17c, Revenues Beat; Offers FY18 Revenue Outlook
-
Horizon Pharma (HZNP) Misses Q1 EPS by 4c, Raises FY Revenue Guidance
-
Horizon Pharma (HZNP) Tops Q4 EPS by 7c, Offers FY Guidance
-
Horizon Pharma (HZNP) Tops Q3 EPS by 4c, Beats on Revenues; Boosts FY17 Revenue & EBITDA Outlook
-
Horizon Pharma (HZNP) Tops Q2 EPS by 31c, Raises Guidance
-
Horizon Pharma (HZNP) Misses Q1 EPS by 2c, Lowers Outlook
-
Horizon Pharma (HZNP) Tops Q4 EPS by 13c
-
Horizon Pharma (HZNP) Announces ACTIMMUNE Phase 3 in FA Missed Primary Endpoint
-
UPDATE: Horizon Pharma (HZNP) Tops Q3 EPS by 7c
-
Horizon Pharma plc (HZNP) to Acquire Raptor Pharmaceutical (RPTP) for $800M
-
Horizon Pharma (HZNP) Tops Q2 EPS by 12c
-
Horizon Pharma (HZNP) Tops Q1 EPS by 4c
-
Horizon Pharma (HZNP) Tops Q4 EPS by 1c
-
Horizon Pharma plc (HZNP) Boosts FY16 Sales, adj.-EBITDA Outlook
-
Horizon Pharma (HZNP) Withdraws Offer to Acquire Depomed (DEPO)
-
Horizon Pharma (HZNP) Tops Q3 EPS by 30c; Boosts FY15 Revenue Outlook
-
Horizon Pharma (HZNP) Tops Q2 EPS by 7c
-
Depomed (DEPO) Board Rejects Horizon Pharma's (HZNP) Revised Takeover Proposal
-
Horizon Pharma (HZNP) Raises Q2, FY15 Revenue Outlook
-
Horizon Pharma (HZNP) Proposes to Acquire Depomed (DEPO) for $29.25/Share
-
Horizon Pharma (HZNP) Reports In-Line Q1 EPS; Lifts FY15 Revenue Outlook
Back to HZNP Stock Lookup